SeaSpine Holdings (SeaSpine Holdings) Cash-to-Debt : 1.08 (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is SeaSpine Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. SeaSpine Holdings's cash to debt ratio for the quarter that ended in Sep. 2022 was 1.08.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, SeaSpine Holdings could pay off its debt using the cash in hand for the quarter that ended in Sep. 2022.

The historical rank and industry rank for SeaSpine Holdings's Cash-to-Debt or its related term are showing as below:

SPNE' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.08 Med: 14.96 Max: No Debt
Current: 1.08

During the past 10 years, SeaSpine Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 1.08. And the median was 14.96.

SPNE's Cash-to-Debt is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.91 vs SPNE: 1.08

SeaSpine Holdings Cash-to-Debt Historical Data

The historical data trend for SeaSpine Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

SeaSpine Holdings Cash-to-Debt Chart

SeaSpine Holdings Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

5.08

10.26

SeaSpine Holdings Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Cash-to-Debt	Get a 7-Day Free Trial															11.94	10.26	2.50	1.54	1.08

Competitive Comparison of SeaSpine Holdings's Cash-to-Debt

For the Medical Devices subindustry, SeaSpine Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SeaSpine Holdings's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SeaSpine Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where SeaSpine Holdings's Cash-to-Debt falls into.

SeaSpine Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

SeaSpine Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	83.106	/	(2.234	+	5.866)
	=	10.26

SeaSpine Holdings's Cash to Debt Ratio for the quarter that ended in Sep. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	46.763	/	(2.412	+	40.936)
	=	1.08

SeaSpine Holdings (NAS:SPNE) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

SeaSpine Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of SeaSpine Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

SeaSpine Holdings (SeaSpine Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SeaSpine Holdings Corp (NAS:SPNE) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

5770 Armada Drive, Carlsbad, CA, USA, 92008

Website

https://www.seaspine.com

SeaSpine Holdings Corp is a medical technology company. The company focuses on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It has orthobiologics and spinal infusion hardware product categories. Its products are anterior and posterior fixation, access systems, bone graft substitutes, and collagen ceramic metrix. The company mainly operates in North America, Europe, Asia-Pacific, and Latin America. It generates revenue by consigning or loaning its products to hospitals and independent sales agents.

Executives

Shweta Maniar	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Beau Standish	officer: President, Enabling Tech	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Paul S. Benny	officer: VP, Corporate Controller	C/O SEASPINE HOLDINGS CORPORATION, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Renee Gaeta	director	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Angela Steinway	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Michael Fekete	director	C/O SAGENT PHARMACEUTICALS, INC., 1901 NORTH ROSELLE ROAD, SUITE 700, SCHAUMBURG IL 60195
Tru St Partnership, L.p.	10 percent owner	795 EAST LANCASTER AVE., STE. 200, VILLANOVA PA 19085
Henneman John B Iii	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Richard E Caruso	10 percent owner	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Keith Valentine	officer: Chief Executive Officer	7475 LUSK BLVD., SAN DIEGO CA 92121
Kimberly Jo Tzoumakas	director	1170 FAIRFAX STREET, BIRMINGHAM MI 48009
Stuart Essig	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Dennis Cirino	officer: Senior VP, Spinal Systems	2361 LOZANA RD, DEL MAR CA 92014
Keith Bradley	director
Tyler Lipschultz	officer: SVP, Orthobiologics and BD	7475 LUSK BLVD, SAN DIEGO CA 92121